Launch a Phase 2 trial in COVID-19 patients in Brazil
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- February 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“This study is anticipated to launch in the first half of 2021.”
What we found
Evidence strength A What the grades mean
The company confirmed that a Phase 2 clinical trial for CNM-ZnAg in COVID-19 patients commenced in Brazil in February 2021, meeting the first-half 2021 deadline.
-
A Clene Inc. 10-K filed 2022-03-11
“We have one clinical trial presently underway which commenced in February 2021 in Brazil, to determine CNM-ZnAg efficacy for the treatment of symptomatic subjects with COVID-19” ✓ confirmed on the page
Market reaction: the shares moved -17.3% against the S&P 500 over the three sessions around the disclosure (10 Mar 2022 to 15 Mar 2022). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Commercial launch
- Indicative materiality
- Medium rules
- Action
- Launch
- Deliverable
- Phase 2 COVID-19 trial
- Where
- Brazil
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Clene Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-CLNN-021075 · Corrections policy